PEZFYLIK

Serial Number 97099276
Registration 7312891
700

Registration Progress

Application Filed
Oct 29, 2021
Under Examination
Approved for Publication
Dec 12, 2023
Published for Opposition
Dec 12, 2023
Registered
Feb 27, 2024

Trademark Image

PEZFYLIK

Basic Information

Serial Number
97099276
Registration Number
7312891
Filing Date
October 29, 2021
Registration Date
February 27, 2024
Published for Opposition
December 12, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 27, 2024
Registration
Registered
Classes
005

Rights Holder

Sun Pharma Advanced Research Company Limited

16
Address
17/B, Mahal Industrial Estate
Mahakali Caves Road, Andheri (East)
Mumbai 400093
IN

Ownership History

Sun Pharma Advanced Research Company Limited

Original Applicant
16
Mumbai IN

Sun Pharma Advanced Research Company Limited

Owner at Publication
16
Mumbai IN

Sun Pharma Advanced Research Company Limited

Original Registrant
16
Mumbai IN

Legal Representation

Attorney
Craig Kuchii

USPTO Deadlines

Next Deadline
1669 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-02-27)
Due Date
February 27, 2030
Grace Period Ends
August 27, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Feb 27, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 27, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 12, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 12, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 22, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 6, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 4, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 4, 2023 ALIE A ASSIGNED TO LIE Loading...
Nov 4, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 3, 2023 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jun 2, 2023 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Jun 2, 2023 PETG O PETITION TO REVIVE-GRANTED Loading...
Jun 2, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 23, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
May 23, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
May 23, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Feb 6, 2023 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Feb 6, 2023 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Feb 6, 2023 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Aug 9, 2022 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Aug 9, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 9, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 9, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Nov 10, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 2, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of ophthalmic diseases and disorders

Classification

International Classes
005